Development

Sentry Biopharma abatement

Summary not yet generated for this topic.

Community sentiment

Supportive (2)

At a glance

Public comments
2
Last 30 days
2

Discussed at 1 meeting in the last 60 days; most recently Nov 9, 2026.

Public comments (2)

SupportivePhil WagnerNov 9, 2026

EDC president pitched the abatement, citing $11.5 million investment, 23 new jobs above the county's wage standard, and cold-chain pharma capability as a recruiting tool.

Council — November 9, 2026 · 2:42 →
SupportiveTim MitchellNov 9, 2026

Company CEO described 20 years in operation, 222 pharma clients, the Columbus site's tornado/flood advantages, and the need for a second power feed from Duke.

Council — November 9, 2026 · 8:00 →